Professor of Pediatrics
Boston Medical Center, Massachusetts
Elisha Wachman, MD is a Professor of Pediatrics at Boston University (BU) Chobanian & Avedisian School of Medicine, Vice Chair for Pediatric Research, and attending neonatologist at Boston Medical Center (BMC). She is an internationally recognized leader in Neonatal Opioid Withdrawal Syndrome (NOWS) and substance use disorders (SUDs) in pregnancy, conducting clinical and translational research and leading quality improvement interventions. Her research has included the investigation of pharmacologic treatment regimens for infants with NOWS, optimal approaches to the pharmacologic treatment of pregnant persons with OUD, clinical, genetic, and epigenetic markers of NOWS outcomes, and the examination of long-term childhood outcomes after prenatal opioid exposure. She is currently the principal investigator (PI) on multiple federal and foundation grants related to the treatment of pregnant individuals with OUD and infants with NOWS. From a clinical care and quality improvement perspective, she is one of the co-leads of the Massachusetts Perinatal Neonatal Quality Improvement Network Perinatal Opioid Project (PNQIN POP) and a co-developer of the Eat, Sleep, Console (ESC) NOWS Care tool. Dr. Wachman is also a co-author on the 2023 Academy of Breastfeeding Medicine international clinical guidelines for breastfeeding in the setting of maternal SUDs.
Improving Outcomes and Mortality from Fentanyl - MOUD Split Dose, Toxicology, Breastfeeding
Friday, April 5, 2024
3:00 PM – 4:15 PM